Subscribe to RSS
DOI: 10.1055/s-0041-1741074
Translation and Validation of COST - FACIT (Version 2) Questionnaire into Hindi and Marathi to Assess Financial Toxicity in Indian Cancer Patients
Abstract
Background Cancer is one of the most expensive and exhaustive medical conditions with a huge impact on the financial condition of the patient and their family members. A lot of advancements have led to improvement in the survival of the patients but at a raised cost. Comprehensive Score for financial Toxicity - Functional Assessment of Chronic Illness Therapy (COST - FACIT Version 2) is one such validated and widely used tool. Assessing the financial burden in our country is still far more challenging as COST - FACIT is available in the English language but not in any regional language. Hence, we decided to validate this tool in Hindi and Marathi languages.
Material and Methods A single-center, cross-sectional study was conducted in the Department of Uro-Oncology at the Tata Memorial Hospital. The original version of the COST - FACIT (Version 2) was translated from English into Hindi and Marathi languages, following the FACIT translation method and tested for content validity that included two forward translations, followed by reconciliation and a backward translation. The questionnaires were then approved by the FACIT team, and pilot testing was done for 20 patients (10 for each Hindi and Marathi language). Each of these 20 patients, after filling up the questionnaire themselves, was interviewed for any difficulty encountered during answering the questionnaire. Based on the suggestions or interpretations of this pilot testing, the necessary changes were incorporated in the final Hindi and Marathi questionnaires.
Results A total of 20 patients (10 each for Hindi and Marathi) were included for pilot testing of the questionnaire. The median age of the entire cohort was 61 years (27–79). The questionnaires showed good content and face validity and demonstrated a high internal consistency (Cronbach's α: 0.85 for Hindi, 0.89 for Marathi).
Conclusion The questionnaire COST - FACIT (Version 2) has been approved and validated in Hindi and Marathi languages by the FACIT team for use in clinical practice and studies.
Institutional Review
The ethical clearance was obtained from the Institutional Ethics Committee at Tata Memorial Hospital, Mumbai, India.
Publication History
Article published online:
25 April 2022
© 2022. MedIntel Services Pvt Ltd. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)
Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India
-
References
- 1 Financial Toxicity and Cancer Treatment (PDQ®) - PDQ Cancer Information Summaries - NCBI Bookshelf [Internet]. [cited 2019 Nov 23]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK384502/
- 2 Chan DNS, Choi KC, Ng MSN. et al. Translation and validation of the Traditional Chinese version of the COmprehensive Score for financial Toxicity-Functional Assessment of Chronic Illness Therapy (Version 2). Health Qual Life Outcomes 2021; 19 (01) 17
- 3 de Souza JA, Yap BJ, Wroblewski K. et al. Measuring financial toxicity as a clinically relevant patient-reported outcome: The validation of the COmprehensive Score for financial Toxicity (COST). Cancer 2017; 123 (03) 476-484
- 4 Definition of financial toxicity - NCI Dictionary of Cancer Terms - National Cancer Institute [Internet]. [cited 2019 Nov 17]. Available from: https://www.cancer.gov/publications/dictionaries/cancer-terms/def/financial-toxicity
- 5 Zafar SY, Peppercorn JM, Schrag D. et al. The financial toxicity of cancer treatment: a pilot study assessing out-of-pocket expenses and the insured cancer patient's experience. Oncologist 2013; 18 (04) 381-390
- 6 Tran G, Zafar SY. Financial toxicity and implications for cancer care in the era of molecular and immune therapies. Ann Transl Med 2018; 6 (09) 166-166
- 7 Fenn KM, Evans SB, McCorkle R. et al. Impact of financial burden of cancer on survivors' quality of life. J Oncol Pract 2014; 10 (05) 332-338
- 8 Many cancer survivors face financial hardships - CBS News [Internet]. [cited 2021 Aug 10]. Available from: https://www.cbsnews.com/news/many-cancer-survivors-face-financial-hardships/
- 9 Barwal VK, Thakur A, Mazta SR, Sharma GA. Out-of-pocket expenditure for diagnosis of lung cancer: a significant pretreatment financial burden – Study from a tertiary care cancer center in North India. CHRISMED J Heal Res 2019; 6 (01) 18-22
- 10 Cronbach's Alpha: Simple Definition, Use and Interpretation - Statistics How To [Internet]. [cited 2021 May 23]. Available from: https://www.statisticshowto.com/probability-and-statistics/statistics-definitions/cronbachs-alpha-spss/
- 11 Wajid M, Rajkumar E, Romate J, George AJ, Lakshmi R. Exploring the problems faced by patients living with advanced cancer in Bengaluru, India. Heliyon 2021; 7 (04) e06686
- 12 Alexander A, Kaluve R, Prabhu JS. et al. The impact of breast cancer on the patient and the family in Indian perspective. Indian J Palliat Care 2019; 25 (01) 66-72
- 13 Pati S, Chauhan AS, Mahapatra S, Nayak S, Nayak S, Weller D. Treatment experiences of women with reproductive cancers in Odisha, India: A qualitative exploration of enablers and barriers. Asian Pac J Cancer Prev 2017; 18 (04) 1019-1024